Skip to content
Screener

Roivant Sciences ROIV Payments to Acquire Property, Plant, and Equipment

Payments to Acquire Property, Plant, and Equipment at other companies

Amgen logo
AmgenAMGN
$513M+39.0%
Revvity logo
RevvityRVTY

Other financials

Income statement

See full
Revenue$1.4M-33.5%
Operating income-$366.0M-28.5%
Net income-$189.8M+15.0%
EPS (diluted)-$0.26+21.2%

Balance sheet

See full
Cash & equivalents$77.1M-18.7%
Total debt$107.2M+7.5%
Total equity$4.2B-2.6%
Total assets$5.3B+5.4%

Cash flow

See full
Operating cash flow-$270.5M-32.4%
CapEx$419.0K-89.6%
Free cash flow-$270.9M-30.0%

Valuation

See full
Market cap$26.25B+244%
Enterprise value$26.28B+244%
P/S3,485×+3,157×

Profitability

See full
Operating margin-9,130.5%-13,995pp
Net margin-6,079.9%-6,193pp
FCF margin-10,901%-22,382pp

Returns & leverage

See full
Return on equity-17.1%-17.7pp
Debt / equity0.0×
Current ratio16.7×-23.8×

Where this comes from

Reported directly by Roivant Sciences in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

The source filing: Roivant Sciences’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 7:28 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q2 2026
Accession
0001635088-26-000090
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025
Proceeds from maturities568,189
Marketable securities, held-to-maturity
Proceeds from maturities720,000
Purchase of property and equipment(419)(4,035)
Net cash provided by (used in) investing activities281,260(1,085,716)
Cash flows from financing activities:
Repurchase of the Company’s common shares(206,729)(208,293)
Proceeds from exercise of the Company’s and subsidiary stock options76,01930,057

Item 1. Financial Statements (Unaudited).

FAQ

What is Roivant Sciences's payments to acquire property, plant, and equipment?
Roivant Sciences (ROIV) reported payments to acquire property, plant, and equipment of $419K in Q2 2026.
How has Roivant Sciences's payments to acquire property, plant, and equipment changed year-over-year?
Roivant Sciences's payments to acquire property, plant, and equipment decreased by 89.6% year-over-year, from $4.04M to $419K.
What is the long-term trend for Roivant Sciences's payments to acquire property, plant, and equipment?
Over 3 years (2021 to 2024), Roivant Sciences's payments to acquire property, plant, and equipment has grown at a -35.9% compound annual growth rate (CAGR), from $17.44M to $4.6M.
What does payments to acquire property, plant, and equipment mean?
Payments to Acquire Property, Plant, and Equipment

Ask your AI about Roivant Sciences's payments to acquire property, plant, and equipment.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude